Zobrazeno 1 - 10
of 32
pro vyhledávání: '"TOMMY WILKMAN"'
Autor:
Markus Atula, Timo Atula, Katri Aro, Heikki Irjala, Elina Halme, Anna Jouppila-Mättö, Petri Koivunen, Tommy Wilkman, Antti Mäkitie, Marko Elovainio, Laura Pulkki-Råback
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Psychosocial factors and socioeconomic status have been associated with incidence, survival, and quality of life among patients with head and neck cancer. We investigated the association between different psychosocial factors, soc
Externí odkaz:
https://doaj.org/article/53f0923a91324a2b94e192206d2afad5
Autor:
Risto Kontio, Tommy Wilkman, Karri Mesimäki, Yurii Chepurnyi, Antti Asikainen, Aleksi Haapanen, Arto Poutala, Marko Mikkonen, Alina Slobodianiuk, Andrii Kopchak
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 5, p 508 (2024)
(1)The study aimed to measure the depth, volume, and surface area of the intact human orbit by applying an automated method of CT segmentation and to evaluate correlations among depth, volume, and surface area. Additionally, the relative increases in
Externí odkaz:
https://doaj.org/article/5d1d3c2cbe044ee09566d538f161c6cf
Autor:
Aini Hyytiäinen, Katja Korelin, Mervi Toriseva, Tommy Wilkman, Satu Kainulainen, Karri Mesimäki, Johannes Routila, Sami Ventelä, Heikki Irjala, Matthias Nees, Ahmed Al-Samadi, Tuula Salo
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-22 (2023)
Abstract Objective Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive tumor with a 5-year mortality rate of ~ 50%. New in vitro methods are needed for testing patients’ cancer cell response to anti-cancer treatments. We aimed to i
Externí odkaz:
https://doaj.org/article/c23305f8303945c3bb4173ddd2f38bea
Autor:
Wafa Wahbi, Katja Korelin, Meri Sieviläinen, Peeter Karihtala, Tommy Wilkman, Jussi Tarkkanen, Tuula Salo, Ahmed Al-Samadi
Publikováno v:
Translational Oncology, Vol 33, Iss , Pp 101677- (2023)
Background: Oral squamous cell carcinoma (OSCC) is a common cancer with a high heterogeneity and few approved treatments. OSCC is one of the least explored areas for precision oncology. In this study, we aimed to test the reliability of our three est
Externí odkaz:
https://doaj.org/article/5e624561f9e943c28f85fa499e51db6f
Autor:
Ahmed Al-Samadi, Katja Tuomainen, Anne Kivimäki, Abdelhakim Salem, Sakhr Al-Kubati, Aini Hyytiäinen, Mataleena Parikka, Karri Mesimäki, Tommy Wilkman, Antti Mäkitie, Reidar Grenman, Tuula Salo
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-6 (2019)
Abstract Background Currently, in vivo model for personalised cancer drug testing is challenging. A zebrafish larvae xenograft model has been applied in recent years to cancer research, particularly for drug testing purposes, showing promising result
Externí odkaz:
https://doaj.org/article/82e9f47114a541f2941ddf4f5511e016
Autor:
Amy Dickinson, Mayank Saraswat, Sakari Joenväärä, Rahul Agarwal, Daniel Jyllikoski, Tommy Wilkman, Antti Mäkitie, Suvi Silén
Publikováno v:
Translational Oncology, Vol 13, Iss 10, Pp 100807- (2020)
Lipid metabolic reprogramming is one hallmark of cancer. Lipid metabolism is regulated by numerous enzymes, many of which are targeted by several drugs on the market. We aimed to characterize the lipid alterations in oral squamous cell carcinoma (OSC
Externí odkaz:
https://doaj.org/article/864f4a035f1b4ba09a82354a73f0d3c2
Autor:
Markus Atula, Katri Aro, Heikki Irjala, Elina Halme, Anna Jouppila‐Mättö, Petri Koivunen, Tommy Wilkman, Henry Blomster, Antti Mäkitie, Timo Atula
Publikováno v:
Head & Neck. 45:1215-1225
Publikováno v:
Anticancer Research. 42:2771-2774
Handgrip strength has been used to evaluate the potential of elderly patients to survive different medical conditions or procedures, or to predict the nutritional status and length of hospitalization. The aim of this study was to evaluate the use of
Autor:
Wafa Wahbi, Katja Korelin, Meri Sieviläinen, Peeter Karihtala, Tommy Wilkman, Jussi Tarkkanen, Tuula Salo, Ahmed Al-Samadi
Background Head and neck squamous cell carcinoma (HNSCC) is a common cancer with a high heterogeneity and few approved treatments. HNSCC is one of the least explored areas for precision oncology. In this study, we aimed to test the reliability of our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afd1cb99ababc6e471148fadc767646c
https://doi.org/10.21203/rs.3.rs-2357747/v1
https://doi.org/10.21203/rs.3.rs-2357747/v1
Autor:
Tommy Wilkman, Anu K. Lappalainen, Bettina Mannerström, Ahmed G. Abu-Shahba, Magdy Adam, Roman Kornilov, Riitta Seppänen-Kaijansinkko, Roy Björkstrand, Jere Lindén, Kati Salla
Publikováno v:
Journal of Dental Research
Funding Information: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Egyptian Ministry of Higher Education and Scientific Research (MoHE)